Shanghai Bao Pharmaceuticals Co., Ltd. (HKG:2659)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
162.60
+7.10 (4.57%)
Last updated: Mar 5, 2026, 3:18 PM HKT
168.76%
Market Cap 52.16B
Revenue (ttm) 51.13M
Net Income (ttm) -416.66M
Shares Out 325.98M
EPS (ttm) -7.40
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 763,303
Average Volume 954,237
Open 155.50
Previous Close 155.50
Day's Range 155.20 - 167.80
52-Week Range 56.00 - 206.00
Beta n/a
RSI 56.72
Earnings Date n/a

About HKG:2659

Shanghai Bao Pharmaceuticals Co., Ltd. operates as a clinical-stage biotechnology company. The company uses synthetic biology technology to develop and deliver recombinant biologic drugs in Mainland China, Hong Kong, Macau, and Taiwan. Its products include KJ017, a recombinant human hyaluronidase; KJ103, an recombinant immunoglobulin G (IgG)-degrading enzyme; SJ02, a long-acting recombinant human follicle-stimulating hormone carboxyl-terminal peptide fusion protein (FSH-CTP); BJ044, a recombinant ulinastatin developed through synthetic biology;... [Read more]

Industry Biological Products, Except Diagnostic Substances
Founded 2019
Employees 348
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 2659
Full Company Profile

Financial Performance

Financial numbers in CNY Financial Statements

News

There is no news available yet.